PROF

Profound Medical Corp. Common Stock

7.42

USD

PROF Earnings Reports

Positive Surprise Ratio

PROF beat 15 of 39 last estimates.

38%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

$7.54M

-$0.28

Implied change from Q3 25 (Revenue/ EPS)

+42.59%

+7.69%

Implied change from Q4 24 (Revenue/ EPS)

+80.54%

+40.00%

Profound Medical Corp. Common Stock earnings per share and revenue

On Nov 13, 2025, PROF reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.36 USD, resulting in a 29.48% surprise. Revenue reached 5.29 million, compared to an expected 5.04 million, with a 4.85% difference. The market reacted with a +7.87% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 7.54 million USD, implying an increase of 7.69% EPS, and increase of 42.59% in Revenue from the last quarter.

FAQ

What were Profound Medical Corp. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Profound Medical Corp. Common Stock reported EPS of -$0.26, beating estimates by 29.48%, and revenue of $5.29M, 4.85% above expectations.

How did the market react to Profound Medical Corp. Common Stock's Q3 2025 earnings?

The stock price moved up 7.87%, changed from $6.35 before the earnings release to $6.85 the day after.

When is Profound Medical Corp. Common Stock expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Profound Medical Corp. Common Stock's next earnings report?

Based on 5 analysts, Profound Medical Corp. Common Stock is expected to report EPS of -$0.28 and revenue of $7.54M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.